Geode Capital Management’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Geode Capital Management’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-331,059	Closed	-$397K	–	4708
2023 Q4	$397K	Buy	331,059 +1,843	+0.6%	+$1.99K	﹤0.01%	3701
2023 Q3	$284K	Buy	329,216 +5,745	+2%	+$6.29K	﹤0.01%	3832
2023 Q2	$388K	Buy	323,471 +161,578	+100%	+$808K	﹤0.01%	3744
2023 Q1	$1.41M	Buy	161,893 +62,033	+62%	+$573K	﹤0.01%	3185
2022 Q4	$798K	Buy	99,860 +25,412	+34%	+$160K	﹤0.01%	3464
2022 Q3	$363K	Buy	74,448 +1,307	+2%	+$8.21K	﹤0.01%	3899
2022 Q2	$406K	Sell	73,141 -122,539	-63%	-$421K	﹤0.01%	3877
2022 Q1	$992K	Buy	195,680 +14,974	+8%	+$120K	﹤0.01%	3622
2021 Q4	$2.33M	Buy	180,706 +50,755	+39%	+$725K	﹤0.01%	3294
2021 Q3	$1.94M	Buy	129,951 +2,233	+2%	+$38.1K	﹤0.01%	3362
2021 Q2	$1.98M	Buy	+127,718	New	+$2.24M	﹤0.01%	3269

Geode Capital Management's RAIN Position: Q1 2024 in Review

Geode Capital Management sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 331,059 shares — an estimated $397K sold.

Geode Capital Management first reported a position in RAIN in Q2 2021 and held it in 11 quarters. The position peaked at $2.33M in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Geode Capital Management reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Geode Capital Management sold 331,059 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $397K.
Geode Capital Management first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 11 quarters.
Geode Capital Management's Rain Oncology Inc. Common Stock position peaked at $2.33M in Q4 2021.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.